Douville Philippe 4
4 · Milestone Pharmaceuticals Inc. · Filed May 14, 2019
Insider Transaction Report
Form 4
Douville Philippe
Chief Scientific Officer
Transactions
- Conversion
Common Shares
2019-05-13+4,124→ 43,392 total - Conversion
Class A-1 Preferred
2019-05-13−4,124→ 0 total→ Common Shares (4,124 underlying)
Footnotes (1)
- [F1]Each share of Class A-1 Preferred was convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, had no expiration date and converted into Common Shares upon the closing of the Issuer's initial public offering.